Guaifenesin 70010-0199
Product NDC
70010-0199- Manufacturer
- Granules Pharmaceuticals Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- August 19, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA213420
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Packaging Options(1)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-199-05)